Xenon Pharmaceuticals (XENE) Earnings Date & Reports

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

XENE is expected to report earnings to fall 1.71% to -114 cents per share on August 12

Xenon Pharmaceuticals XENE Stock Earnings Reports

Q2'26

Est.

$-1.15

Q1'26

Beat

by $0.01

Q4'25

Missed

by $0.12

Q3'25

Est.

$-1.15

Q2'25

Beat

by $2.06

The last earnings report on May 07 showed earnings per share of -116 cents, beating the estimate of -117 cents. With 733.02K shares outstanding, the current market capitalization sits at 5.30B.

View a ticker or compare two or three

Compare

XENE

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for XENE